Navigation Links
FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
Date:4/3/2012

ood test on the market that accurately predicts the risk of near term (2-3 years) myocardial infarction or death in patients with suspected or confirmed, insignificant or significant coronary artery disease. Research has discovered that there are multiple pathways that lead to formation of vulnerable plaques. PREvent aggregates three cardiovascular biomarkers that identify these pathways, and projects the propensity for an individual to develop vulnerable plaque. PREvent provides physician's diagnostic clarity in identifying CAD patients that are in most urgent need of aggressive treatment, compliance and monitoring.

About FirstMark

FirstMark is a division of GenWay Biotech, Inc. The FirstMark division is focused on the development and commercialization of non-invasive diagnostic and health monitoring tests for unmet clinical needs. Headquarters are located in the heart of San Diego's biotech community in the Sorrento Valley/Mesa area. For additional information please visit FirstMarkPREvent.com.

Media Contact:

Deborah Moore GenWay Biotech, 858-458-0866, dmoore@genwaybio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE FirstMark
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
2. ChromaDex® Announces Financial Results for the Year Ended 2011
3. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
4. Pew announces 2012 recipients of distinguished Marine Conservation Fellowship
5. PNAS announces 6 2011 Cozzarelli Prize recipients
6. ChromaDex® Announces Management Changes
7. Collaborative Health Consortium Announces eCollaboration Forum Final Agenda for HIMSS 2012
8. Medbox, Inc. Announces New Product Line for 2012
9. FASEB SRC announces conference registration open for: Virus Structure and Assembly
10. Elsevier announces publishing the Ocular Surface
11. Biophysical Society announces New and Notable Symposium speakers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... WHEN: , Saturday to Wednesday, Oct. 18-22, 2014 ... 111 W. Harbor Drive, San Diego, CA 92101 ... sessions and other presentations of the latest research ... Opening plenary session featuring high-scoring abstracts on rare ... of various cancers, and treatment for sun sensitivity ...
(Date:8/21/2014)... successfully replicated one of the crucial steps in photosynthesis, ... which could manufacture hydrogen as a fuel. , "Water ... exciting prospect to use them to create hydrogen, and ... from the ARC Centre of Excellence for Translational Photosynthesis ... offers potential as a zero-carbon replacement for petroleum products, ...
(Date:8/20/2014)... 158 pregnant teenagers in Rochester, NY, nearly half engaged ... ice, cornstarch, vacuum dust, baby powder and soap, and ... Moreover, such teens had significantly lower iron levels as ... , Pregnant teens, regardless of pica, are at higher ... deficiency and anemia. Low iron in pregnant teens raises ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2Water and sunlight the formula for sustainable fuel 2Pica in pregnant teens linked to low iron 2
... HOUSTON -- A comprehensive drug development strategy that ... then narrows down to a small-molecule prototype has yielded ... ways, a team led by scientists at The University ... two papers published back-to-back online at the Proceedings ...
... to detect nuclear explosions and enforce the world,s nuclear ... volcanoes in the Northern Mariana Islands near Guam. The ... for forward deployment of U.S. military forces in the ... U.S. Geological Survey and Southern Methodist University in Dallas ...
... provide powerful protection against risks her baby faces in the ... the journal Biological Psychiatry . The research shows that ... to be a harbinger for babies, poor cognitive development ... care during infancy and toddler-hood. The new study represents ...
Cached Biology News:New strategy develops 2 prototype drugs against cancer, retinal diseases 2New strategy develops 2 prototype drugs against cancer, retinal diseases 3Volcano monitoring will target hazard threat to Marianas, US military and commercial jets 2Volcano monitoring will target hazard threat to Marianas, US military and commercial jets 3Volcano monitoring will target hazard threat to Marianas, US military and commercial jets 4Good parenting triumphs over prenatal stress 2Good parenting triumphs over prenatal stress 3
(Date:8/21/2014)... Aug. 21, 2014  China Cord Blood Corporation (NYSE: ... to release financial results for the first quarter of ... market close in the US.  The ... ET on Friday, August 29, 2014 to discuss its ... Company,s recent developments, followed by a question and answer ...
(Date:8/21/2014)... August 21, 2014 Gallus ... contract development and manufacturing organization (CMO) announced today ... Inc., an oncology company focused on the development ... to manufacture the anti-prostate specific membrane antigen (PSMA) ... candidate. Under the agreement the antibody will ...
(Date:8/20/2014)... analysis of patented university inventions licensed to biotechnology ... to commercialization. To open these roadblocks, the researchers ... during the discovery stage could lead to faster ... frequently derived from discoveries made in university laboratories ... known during clinical trials, which have a high ...
(Date:8/20/2014)... Livermore, California (PRWEB) August 20, 2014 ... to develop and apply the most complete climate ... challenging and demanding climate change issues. , Eight ... combining forces with the National Center for Atmospheric ... in the new effort. Other participating national laboratories ...
Breaking Biology Technology:China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3
... Technology Center (HTC), Texas, largest technology incubator and ... of Entrepreneurs . "  The event honored local entrepreneurs ... economy; and developed lifesaving and revolutionary technologies. ... TechTrans International, Inc., as this year,s honoree. As the Founder ...
... May 20, 2012 A team of Australian scientists has ... of people with bowel cancer. The discovery has ... would signal the early stages of bowel cancer. This test ... programs and encouraging those at risk to have a colonoscopy. ...
... NEW YORK, May 17, 2012   Pharmaceutical companies ... value could have an advantage in the competition for ... published today by the Health Research Institute (HRI) at ... to know how well a drug will work and ...
Cached Biology Technology:Leading Technology Incubator Honors Extraordinary Entrepreneurs 2Leading Technology Incubator Honors Extraordinary Entrepreneurs 3Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer 2Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer 3New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 2New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 3New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 4New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 5New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 6
... RNase H- Reverse Transcriptase ... version of SuperScript™ II ... SuperScript™ II it synthesizes ... from single-stranded RNA DNA ...
versican (H-56)...
... Heraeus HERAcell is the ideal CO2 incubator ... of ova or embryos at or near ... to provide everything needed to protect and ... Safe and stable incubation conditions ensure optimum ...
... presents PsiPort Mass Directed Auto Purification ... data acquisition system designed for automated ... life science and pharmaceutical discovery programs. ... to simplify high throughput mass directed ...
Biology Products: